This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Phytiva Brand Gets Set To Release Cannabis Based Formulations Product Lines For The Multi-Billion Dollar Medical Cannabis Market, Newly Opened Social Use, And OTC Markets By Issuing A Stronger Outlook For 2013

DALLAS, Dec. 19, 2012 /PRNewswire/ -- X-Change Corp (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is cannabis and hemp based extracts targeting Medical Cannabis, Cosmeceutical and Neutroceuticals and Social Usage solutions through multiple Phytiva Brand Product Lines. The Company issues a stronger outlook for 2013 based on new Phytiva Product Lines for the Medical Cannabis Industry as a whole. These new Phytiva Product Lines will be launched with Cannabis based formulations through Medical Cannabis dispensaries, Cannabis laboratories, and individual legal State grow operations on a State by State approved basis.   

The Company is working with approved partners operating in legal jurisdictions under State approved permits developing its newest Cannabis based Phytiva Product lines that have identified over a dozen ailments that we believe that our products will be the superior choice on the market.  These ailments include cancer, arthritis, influenza, HIV/ AIDS, PTSD and many more.

The global markets that the Phytiva product lines are targeting is enormous.  The Cancer industry is estimated at $300 billion globally by 2025, the HIV Therapeutics market is estimated to be $21.8 Billion by 2018.  This is in addition to the PTSD Therapeutics market which was worth $1.3 Billion in 2011.  Recently, a cure for Cancer, if realized, is estimated to be worth over $ 1 trillion. Social use has just become available in Washington State and Oregon, many numbers are reported very high, but the Company is awaiting official word.

X-Change Corporation through its Phytiva Brand Product line intends  to release product formulations that include high-level CBD's and variations of THC, CBD's, and other cannabinoid elements. These formulations will be in addition to the existing development of the hemp extract based products forthcoming in 2013.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs